Search Results

There are 11282 results for: content related to: Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients

  1. You have free access to this content
    Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community


    Volume 121, Issue 1, January 1, 2015, Pages: 93–101, Dolly C. Penn, YunKyung Chang, Anne-Marie Meyer, Christina DeFilippo Mack, Hanna K. Sanoff, Karyn B. Stitzenberg and William R. Carpenter

    Version of Record online : 10 SEP 2014, DOI: 10.1002/cncr.29028

  2. You have free access to this content
    Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice


    Volume 121, Issue 19, October 1, 2015, Pages: 3428–3434, Anne-Sophie Dussol, Marie-Odile Joly, Cecile Vercherat, Julien Forestier, Valérie Hervieu, Jean-Yves Scoazec, Catherine Lombard-Bohas and Thomas Walter

    Version of Record online : 8 JUN 2015, DOI: 10.1002/cncr.29517

  3. You have free access to this content
    Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer


    Volume 118, Issue 17, 1 September 2012, Pages: 4309–4320, Hanna K. Sanoff, William R. Carpenter, Janet Freburger, Ling Li, Kun Chen, Leah L. Zullig, Richard M. Goldberg, Maria J. Schymura and Deborah Schrag

    Version of Record online : 31 JAN 2012, DOI: 10.1002/cncr.27422

  4. Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer


    Volume 123, Issue 22, November 15, 2017, Pages: 4506–4514, Satoshi Okazaki, Marta Schirripa, Fotios Loupakis, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Martin D. Berger, Yuji Miyamoto, Mitsukuni Suenaga, Syma Iqubal, Afsaneh Barzi, Chiara Cremolini, Alfredo Falcone, Francesca Battaglin, Lisa Salvatore, Beatrice Borelli, Timothy G. Helentjaris and Heinz-Josef Lenz

    Version of Record online : 14 JUL 2017, DOI: 10.1002/cncr.30880

  5. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  6. You have free access to this content
    Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults


    Volume 118, Issue 11, 1 June 2012, Pages: 2925–2934, Christina D. Mack, William Carpenter, Anne-Marie Meyer, Hanna Sanoff and Til Stürmer

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26622

  7. Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

    Asia-Pacific Journal of Clinical Oncology

    Volume 11, Issue 4, December 2015, Pages: 334–342, Young Suk Park, Jiafu Ji, John Raymond Zalcberg, Mostafa El-Serafi, Antonio Buzaid and Marwan Ghosn

    Version of Record online : 15 OCT 2015, DOI: 10.1111/ajco.12409

  8. You have free access to this content
    Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer


    Volume 119, Issue 11, 1 June 2013, Pages: 1941–1950, Janghee Woo, Neil Palmisiano, William Tester and John C. Leighton Jr.

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.27994

  9. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study


    Elizabeth M. Cespedes Feliciano, Valerie S. Lee, Carla M. Prado, Jeffrey A. Meyerhardt, Stacey Alexeeff, Candyce H. Kroenke, Jingjie Xiao, Adrienne L. Castillo and Bette J. Caan

    Version of Record online : 7 SEP 2017, DOI: 10.1002/cncr.30950

  10. Real-world resource use and costs of adjuvant treatment for stage III colon cancer

    European Journal of Cancer Care

    Volume 24, Issue 3, May 2015, Pages: 321–332, C.W.M. van Gils, S. de Groot, S.S. Tan, W.K. Redekop, M. Koopman, C.J.A. Punt and C.A. Uyl-de Groot

    Version of Record online : 25 DEC 2013, DOI: 10.1111/ecc.12154

  11. You have free access to this content
    Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study


    Volume 119, Issue 19, 1 October 2013, Pages: 3570–3577, Andreas A. Argyriou, Guido Cavaletti, Anna Antonacopoulou, Armando A. Genazzani, Chiara Briani, Jordi Bruna, Salvatore Terrazzino, Roser Velasco, Paola Alberti, Marta Campagnolo, Sara Lonardi, Diego Cortinovis, Marina Cazzaniga, Cristina Santos, Aikaterini Psaromyalou, Aikaterini Angelopoulou and Haralabos P. Kalofonos

    Version of Record online : 2 JUL 2013, DOI: 10.1002/cncr.28234

  12. You have free access to this content
    Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients


    Volume 118, Issue 12, 15 June 2012, Pages: 3173–3181, C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya and Nader Hanna

    Version of Record online : 21 OCT 2011, DOI: 10.1002/cncr.26613

  13. Effects of oxaliplatin and oleic acid Gc-protein-derived macrophage-activating factor on murine and human microglia

    Journal of Neuroscience Research

    Volume 93, Issue 9, September 2015, Pages: 1364–1377, Jacopo J.V. Branca, Gabriele Morucci, Francesca Malentacchi, Stefania Gelmini, Marco Ruggiero and Stefania Pacini

    Version of Record online : 18 MAR 2015, DOI: 10.1002/jnr.23588

  14. You have free access to this content
    Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01


    Volume 118, Issue 22, 15 November 2012, Pages: 5614–5622, Kelley M. Kidwell, Greg Yothers, Patricia A. Ganz, Stephanie R. Land, Clifford Y. Ko, Reena S. Cecchini, Jacek A. Kopec and Norman Wolmark

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27593

  15. Oral versus intravenous fluoropyrimidines for colorectal cancer

    Intervention Review

    The Cochrane Library

    Fiona Chionh, David Lau, Yvonne Yeung, Timothy Price and Niall Tebbutt

    Published Online : 28 JUL 2017, DOI: 10.1002/14651858.CD008398.pub2

  16. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma


    Volume 123, Issue 18, September 15, 2017, Pages: 3494–3501, Robert R. McWilliams, Nathan R. Foster, Michelle R. Mahoney, Thomas C. Smyrk, Joseph A. Murray, Matthew M. Ames, L. Elise Horvath, Daniel J. Schneider, Timothy J. Hobday, Aminah Jatoi, Jeffrey P. Meyers and Matthew P. Goetz

    Version of Record online : 10 MAY 2017, DOI: 10.1002/cncr.30766

  17. You have free access to this content
    Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea


    Volume 121, Issue 1, January 1, 2015, Pages: 84–92, Yehua Shen, Luming Liu, Joseph S. Chiang, Zhiqiang Meng, M. Kay Garcia, Zhen Chen, Huiting Peng, Wenying Bei, Qi Zhao, Amy R. Spelman and Lorenzo Cohen

    Version of Record online : 9 SEP 2014, DOI: 10.1002/cncr.28973

  18. You have free access to this content
    PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 243–250, Masanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, Hirotaka Shimaoka, Naohiro Suzuyama, Kotaro Sakamoto, Arisa Fujita, Naoki Ogawa, Tatsuki Itoh, Motohiro Imano, Yoshinori Funakami, Seiji Ichida, Takao Satou and Shozo Nishida

    Version of Record online : 8 DEC 2014, DOI: 10.1002/ijc.29367

  19. Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis


    Volume 123, Issue 23, December 1, 2017, Pages: 4680–4686, Mohamad Bassam Sonbol, Belal Firwana, Zhen Wang, Diana Almader-Douglas, Mitesh J. Borad, Issam Makhoul, Ramesh K. Ramanathan, Daniel H. Ahn and Tanios Bekaii-Saab

    Version of Record online : 17 AUG 2017, DOI: 10.1002/cncr.30927

  20. The role of oxaliplatin in the management of upper gastrointestinal tract malignancies

    Colorectal Disease

    Volume 5, Issue s3, November 2003, Pages: 36–44, W. Scheithauer and E. Van Cutsem

    Version of Record online : 30 OCT 2003, DOI: 10.1046/j.1463-1318.5.s3.5.x